<DOC>
	<DOCNO>NCT02250690</DOCNO>
	<brief_summary>The aim present study analyze effect consecutive session Transcranial direct current stimulation associate kinesiotherapy gait performance Parkinson ' disease . For , primary outcome evaluation gait performance mean space temporal parameter speed ( meter/second ) , stride frequency ( steps/min ) stride length ( ) . The secondary outcome motor cortex excitability analyze mean single pulse transcranial magnetic stimulation ( TMS ) intend determine : motor evoke potential amplitude ( MEP ) rest motor threshold ( rMT ) .</brief_summary>
	<brief_title>Neuromodulation Motor Function Parkinson 's Disease</brief_title>
	<detailed_description>This study consist intervention involve screening follow evaluation , volunteer subject many test : history , session III Unified Scale Modified Parkinson 's Disease - Unified Parkinson 's Disease Rating Scale , Ten meter walk test - Walk Test 10 meter shoot gait , ( use Studio Version 8 software ) . On day , subject underwent assessment brain excitability determine motor threshold amplitude motor evoke potential ( MEP ) . The randomization volunteer conduct external search opaque envelope order accord random distribution . The subject divide two group : control group , group submit Transcranial Stimulation session sham Continuous Current ( sham tDCS ) gait training , Experimental group , subject stimulation Transcranial Direct Current session ( active tDCS ) gait training .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Main eligibility criterion idiopathic Parkinson 's disease Both sex Hoehn Yahr stage I III Showing mild severe gait disturbance Stable medication usage Age 40 80 year And absence cognitive impairment disorder interfere participation cue therapy . Presence chronic disabling pathology lower limb Presence pacemaker severe cardiovascular condition A history tumor , prior neurosurgical brain Intervention , severe cardiovascular condition , include presence pacemaker A diagnosis epilepsy major psychiatric disorder . Participants neurological , muscular , psychiatric disorder ( e.g . peripheral neuropathy , uncorrected visual problem , hear problem , vestibular dysfunction , stroke , seizure , migraine , frequent severe headache ) exclude . Participants surgical implant , significant postural tremor , dyskinesia , severe freeze dementia also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>idiopathic PD</keyword>
	<keyword>Hoehn Yahr stage I III</keyword>
	<keyword>stable medication usage</keyword>
	<keyword>age 40 80 year</keyword>
	<keyword>absence cognitive impairment</keyword>
</DOC>